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Abstract objectives To describe the epidemiology and an aetiological model of ocular surface squamous
neoplasia (OSSN) in Africa.
methods Systematic and non-systematic review methods were used. Incidence was obtained from
the International Agency for Research on Cancer. We searched PubMed, EMBASE, Web of Science
and the reference lists of articles retrieved. Meta-analyses were conducted using a fixed-effects model
for HIV and cigarette smoking and random effects for human papilloma virus (HPV).
results The incidence of OSSN is highest in the Southern Hemisphere (16 South), with the highest
age-standardised rate (ASR) reported from Zimbabwe (3.4 and 3.0 cases/year/100 000 population for
males and females, respectively). The mean ASR worldwide is 0.18 and 0.08 cases/year/100 000
among males and females, respectively. The risk increases with exposure to direct daylight (2–4 h,
OR = 1.7, 95% CI: 1.2–2.4 and ≥5 h OR = 1.8, 95% CI: 1.1–3.1) and outdoor occupations
(OR = 1.7, 95% CI: 1.1–2.6). Meta-analysis also shows a strong association with HIV (6 studies:
OR = 6.17, 95% CI: 4.83–7.89) and HPV (7 studies: OR = 2.64, 95% CI: 1.27–5.49) but not
cigarette smoking (2 studies: OR = 1.40, 95% CI: 0.94–2.09). The effect of atopy, xeroderma
pigmentosa and vitamin A deficiency is unclear.
conclusions Africa has the highest incidence of OSSN in the world, where males and females are
equally affected, unlike other continents where male disease predominates. African women probably
have increased risk due to their higher prevalence of HIV and HPV infections. As the survival of
HIV-infected people increases, and given no evidence that anti-retroviral therapy (ART) reduces the
risk of OSSN, the incidence of OSSN may increase in coming years.
keywords ocular surface squamous neoplasia, conjunctival intraepithelial neoplasia, conjunctival
intraepithelial dysplasia, ocular surface epithelial dysplasia, conjunctival squamous cell carcinoma,
risk factors, incidence
Introduction
Ocular surface squamous neoplasia (OSSN) is the most
common ocular surface tumour (Grossniklaus et al.
1987). Other synonymous terms include ‘conjunctival
epithelial neoplasia’, ‘ocular surface epithelial dysplasia’
and ‘conjunctival squamous cell neoplasia’ (Lee & Hirst
1992; McDonnell et al. 1992; Tulvatana 2003). OSSN
covers a spectrum of disease ranging from non-invasive
intra-epithelial dysplasia of the conjunctiva and cornea
(CCIN) to invasive squamous cell carcinoma (Lee &
Hirst 1995).
Clinical features
The disease may present with irritation, red eye, raised
gelatinous mass and leucoplakia (Tunc et al. 1999). In
Africans, it is often pigmented brown (Figure 1). OSSN is
usually unilateral (Chisi et al. 2006) and arises at the
limbus – the junction between the cornea and conjunctiva
(Lee & Hirst 1997). Most lesions occur within the
exposed part of the eyeball between the lids (Ateenyi-
Agaba 1995; McKelvie 2002; Waddell et al. 2006). Up
to 31.2% of cases seen are recurrent lesions (Chisi et al.
2006). Late stages present with a large fungating oculo-
orbital mass (Ogun et al. 2009). Early lesions resemble
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benign growths such as pterygia and pingueculae. OSSN
can be the first manifestation of HIV infection in about
50% of cases in HIV-endemic settings (Porges &
Groisman 2003; Spitzer et al. 2008).
Histopathology
Histologically, OSSN may be classified into 3 forms:
benign, pre-invasive and invasive (Table 1; Basti &
Macsai 2003). The term OSSN usually excludes the
benign forms. The term ‘invasive’ indicates infiltration
through the basement membrane of the conjunctival
epithelium into the underlying stroma (Basti & Macsai
2003; Shields & Shields 2004).
Epidemiology overview
Two disease patterns of OSSN are recognised: older,
predominantly male in temperate climates, not associated
with HIV or human papilloma virus (HPV); and younger
men and women, in tropical climates, associated with
HIV and HPV. The latter represents a public health chal-
lenge in Africa in relation to the HIV pandemic and late
presentation of large tumours (Ukponmwan et al. 2002;
Chisi et al. 2006; Ogun et al. 2009), diagnostic difficul-
ties (Furahini & Lewallen 2010), malignant transforma-
tion and high recurrence rates after treatment (1-year
recurrence of 16.6% reported in Tanzania; Makupa et al.
2012). Experienced surgeons report lower recurrences
(3.2%) after excision (Waddell et al. 2006). Trial data to
guide management in this context are lacking (Gichuhi &
Irlam 2013). For the temperate pattern of disease, one
randomised controlled crossover trial in Australia
compared mitomycin-C with placebo in participants
(a) Small lesion with leuloplakia (b) Medium sized lesion with 
pigmentation
(c) Large lesion with corneal extension
but not involving the fornices
(d) Very large lesion extending into the
 orbit
Figure 1 A range of clinical
presentations of ocular surface squamous
neoplasia (OSSN) in East Africa. (a)
Small lesion with leukoplakia; (b)
Medium sized lesion with pigmentation;
(c) Large lesion with corneal extension
but not involving the fornices; (d) Very
large lesion extending into the orbit.
Table 1 Histopathological classification of ocular surface squa-
mous neoplasia (OSSN), Basti & Macsai (2003) and American
Joint Committee on Cancer (2010)
Benign
Squamous papilloma
Pseudoepitheliomatous hyperplasia
Benign hereditary intraepithelial dyskeratosis
Pre-invasive
Conjunctival intraepithelial neoplasia (CIN)
CIN I (mild dysplasia) – confined to the basal third of the
conjunctival epithelium
CIN II (moderate dysplasia) – extends into the middle third
of the conjunctival epithelium
CIN III (severe dysplasia) – extends into the superficial third
of the conjunctival epithelium
CIS (carcinoma-in-situ) – full thickness dysplasia*
Invasive
Squamous cell carcinoma
GX – grade cannot be defined
G1 – Well differentiated
G2 – Moderately differentiated
G3 – Poorly differentiated
G4 – undifferentiated
Mucoepidermoid carcinoma
*The American Joint Committee on Cancer (AJCC) staging
manual 2010 classifies CIS under CIN.
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whose average age was 67 years (Hirst 2007). There was
a significant treatment effect on clinically assessed com-
plete resolution of lesions (P = 0.0005), but no effect on
histologically assessed complete resolution (P = 0.49).
Incidence rates and geographical variation
Incidence estimates for OSSN are difficult to ascertain
and vary regionally (Table 2). The first paper to examine
this used cancer registry data from International Agency
for Research on Cancer (IARC; Newton et al. 1996). A
subset of these data were used in a subsequent publica-
tion looking at variation in incidence across the USA
(Emmanuel et al. 2012). However, published results need
to be interpreted with caution – firstly, all eye cancers are
classified together by the International Classification of
Diseases for Oncology (ICD-O-3 C.69) while other
databases classify squamous cell carcinoma of the
conjunctiva (SCCC) with head and neck cancers (Lee
et al. 2000; Curado et al. 2007; Parkin et al. 2010).
OSSN is not recognised as a separate entity. Squamous
cell carcinomas that are site-coded for the eye (C69)
probably include some cancers that originate in the eyelid
skin (WHO 2000, 2010; Curado et al. 2007). Secondly,
the availability of histopathology services to confirm
OSSN diagnosis is often limited in low- and middle-
income countries (Furahini & Lewallen 2010). Thirdly,
health information systems tend to capture invasive squa-
mous cell carcinoma (SCC) but not earlier stages. Coun-
tries reporting higher rates of SCC (mostly in Africa)
only started sending cancer registry data to IARC in the
mid-1980s (Curado et al. 2007). Completeness of the
current IARC database is hampered in that only data
from 80 countries were submitted, of which 75% was of
acceptable quality, and not all countries had data on
squamous cell carcinoma in the eye under code C69.
Africa had the lowest level of acceptable quality of data
(36%). Fourthly, crude incidence rates can be influenced
by population structure, a problem often addressed by
reporting age-standardised incidence rates. Finally, in
areas with limited health facilities for cancer treatment
where a large number of patients are treated outside the
reference area, incidence may be underestimated.
Moreover, in defining incidence from different sources, it
may be difficult to distinguish between recurrence or
extension of an existing cancer on one hand and the
development of a new primary on the other. Analysis of
incidence time trends is also difficult if geographical
coverage, ICD revisions and disease definitions in a
registry change.
Methods for this review
Systematic and non-systematic review methods were
used. No a priori systematic review protocol had been
published. Incidence data were obtained from the cur-
rent IARC report (9th Volume) covering the period
1998–2002. The IARC collates data from cancer regis-
tries worldwide. The report uses ICD codes to show the
age-standardised incidence per 100 000 population strat-
ified by sex and histological type. Under code C.69
where eye cancers are reported, the four main groups
are retinoblastoma, malignant melanoma, carcinomas
(11.4% of all eye cancers), sarcoma and other unspeci-
fied tumours. Under carcinomas, there are three sub-
groups – SCC (principally tumours of the conjunctiva
and cornea, comprising 70% of the carcinoma sub-
group), other specified carcinoma (adenocarcinomas of
the lacrimal gland and lacrimal duct) and unspecified
carcinomas. We extracted data from the SCC subgroup.
Table 2 Age-standardized incidence rates of squamous cell carcinoma in the eye (ICD-O-3 C.69) by continent for the period 1998–
2002 (Curado et al. 2007)
Region
Age-standardized incidence rate (cases/year/100 000 pop)
P-valueMales mean (95% CI) Females mean (95% CI)
Africa 1.38 (1.00 to 3.75) 1.18 (1.08 to 3.43) 0.853
Central & South America 0.48 (0.33 to 0.62) 0.21 (0.10 to 0.33) 0.005
Oceania 0.28 (0.14 to 0.41) 0.05 (0.01 to 0.10) 0.002
North America 0.08 (0.06 to 0.10) 0.00 (0.00 to 0.01) <0.001
Asia 0.08 (0.01 to 0.14) 0.05 (0.00 to 0.09) 0.416
Europe 0.05 (0.02 to 0.08) 0.01 (0.00 to 0.03) 0.033
Southern Hemisphere 0.61 (0.14 to 1.09) 0.33 (0.12 to 0.78) 0.355
Northern Hemisphere 0.10 (0.06 to 0.14) 0.05 (0.00 to 0.08) 0.045
Worldwide estimate 0.18 (0.09 to 0.26) 0.08 (0.01 to 0.15) 0.091
CI = confidence interval.
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The coordinates locating each registry were obtained
from http://itouchmap.com/latlong.html.
We searched PubMed, EMBASE and Web of Science
for systematic reviews, meta-analysis and case–control
studies using ‘OSSN’, ‘conjunctival squamous cell carci-
noma’, ‘risk factors’ and their synonyms as key words
with no language restrictions. Abstracts were assessed
and studies were selected if they reported analysis of
known or suspected risk factors. The search was con-
ducted on 2 January 2013 and updated on 31 May 2013.
Data were extracted from the full texts of articles and
additional articles obtained from their reference lists.
Meta-analyses were conducted where appropriate. A
fixed-effects model was used for HIV and cigarette
smoking. A random-effects model was chosen for HPV
after investigation of heterogeneity.
Results and discussion
Africa has the highest age-standardised incidence rate of
ocular SCC followed by Central and South America then
Oceania (Australia, New Zealand and Hawaii), respec-
tively (Table 2 and Figure 2). The rate in Africa is about
9–10 times higher than in Europe and North America.
The highest incidence rate is 3.4 cases/year/100 000
among males and 3.0 cases/year/100 000 among females
in Zimbabwe (Curado et al. 2007). Uganda follows with
1.6 cases/year/100 000 for males and females. Australia
comes third with 0.3–0.5 cases/year/100 000 in parts of
that country. Other countries have rates between 0 and
0.1 cases/year/100 000. The rates have a right-skewed
bell-shaped distribution peaking at latitude 16 South
(Figure 3). Incidence rates are higher in the Southern
Hemisphere than the Northern Hemisphere, with male
ASR = 0.61 cases/year/100 000 (95% CI: 0.14–1.09) and
female ASR = 0.33 (95% CI: 0.12 to 0.78) in the
Southern Hemisphere, compared with male ASR = 0.10
(95% CI: 0.06–0.14) and female ASR = 0.05 (95% CI:
0.00–0.08) in the Northern Hemisphere.
The high rates in Africa are consistent with other esti-
mates from the region. A Tanzanian study estimated the
incidence of suspected OSSN from 2006 to 2008 using
operating theatre records across the country. Although
there was no histological confirmation in all cases, the inci-
dence was found to be 2.2 cases/year/100 000 (Furahini &
Lewallen 2010). Uganda reported a peak incidence of 3.5
cases/year/100 000 in 1992 (Ateenyi-Agaba 1995). More
recent data from the Kampala Cancer Registry also show a
marked increase, although it is reported as ocular cancer,
rather than specifically as OSSN (Wabinga et al. 2000).
Cancer registry data in two African countries show
that OSSN has become more prevalent with time. In
Zimbabwe, the age-adjusted annual incidence rates of
SCCC underwent a more than 10-fold increase from 0.17
to 1.8/100 000 between 1990 and 1999 (Masanganise
et al. 2008) while the prevalence of OSSN among ocular
KEY:  Dot size is directly proportional to incidence. Males are shown in blue and females in red.
Overlaps between males and females appear purple in colour
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Figure 2 Worldwide mapping of the age-standardized incidence rates (ASR) of squamous cell carcinoma of the eye (ICD-O-3 C.69)
for the period 1998–2002 (Curado et al. 2007). Key: Dot size is directly proportional to incidence. Males are shown in blue and
females in red. Overlaps between males and females appear purple in colour.
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surface tumour biopsy specimens increased from 33% in
1996 to 58% by 2000 (Pola et al. 2003).
OSSN is the most common indication for orbital exentera-
tion performed in adults in Africa (Table 3; Pola et al 2003).
This surgical procedure to excise all the orbital tissue includ-
ing stripping the periosteum from the orbital walls is per-
formed in cases with advanced disease. More than half
(≥57%) the exenterations performed in Africa are for OSSN
compared with 32% in Australia and 9–15% in Europe and
India. Although available data does not clearly distinguish
those performed for primary eyelid disease from conjunctival
disease, SCC still emerges as an important cause in Africa.
Eyelid SCC is uncommon in Africa (Templeton 1967, 1973).
Incidence of OSSN by age and sex
In temperate countries, OSSN remains a rare, slow-
growing tumour of elderly males (70–80% are males
with a mean age of about 60 years; Lee & Hirst 1997;
Tunc et al. 1999). In contrast, in tropical countries,
particularly in Eastern and Southern Africa, the preva-
lence is highest among young people in their 30s and
among women (50–70%; Table 4; Poole 1999; Pola
et al. 2003; Chisi et al. 2006; Furahini & Lewallen
2010). Within East Africa, the pattern of SCCC in the
1960s differed to that seen today. In 1967, the average
age of affected patients was 48 years, and males were
four times more frequently affected than females
(Templeton 1967).
Worldwide, IARC data show that the overall incidence
is higher in males than females but the difference is not
statistically significant (Figure 3 and Table 2). The mean
male ASR worldwide is 0.18 cases/year/100 000 (95%
CI: 0.09–0.26) and 0.08 (95% CI: 0.01–0.15) among
females (P = 0.09). Incidence is significantly higher in
males than females except in Africa and Asia where both
4
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Figure 3 The age-standardized incidence
rates (ASR) of squamous cell carcinoma
of the eye (ICD-O-3 C.69) for the period
1998–2002 (Curado et al. 2007).
Table 3 The proportion of orbital exenterations performed due to ocular squamous cell carcinoma in different regions of the world
Year (ref.) Country No. of exenterations (N) No. due to SCCC (n) Proportion (n/N) (%)
2011 (Ackuaku-Dogbe 2011) Ghana 25 19 76
2001 (Masanganise & Magava 2001) Zimbabwe 23 13 57
2007 (Nemet et al. 2007) Australia 38 12 32
2004 (Pushker et al. 2004) India 26 3 15
2008 (Croce et al. 2008) Italy* 6 1 13
2005 (Rahman et al. 2005) UK† 69 6 9
*Included children.
†Mainly elderly patients.
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sexes are equally affected (Table 2). Prevalence in Africa
is higher in females than males (Table 4). This may be
related to Africa having the highest prevalence of both
HIV and HPV, which may increase the risk of OSSN in
women and gender differences in mortality of HIV-
infected adults. In South Africa, HIV-infected females
have a longer life expectancy than HIV-infected males
(Cornell et al. 2012; Johnson et al. 2013; Maskew et al.
2013). Men present in later stages of HIV/AIDS for anti-
retroviral therapy (ART) and possibly have poorer adher-
ence to ART (Taylor-Smith et al. 2010). This has also
been observed in Latin America, China and Lao (Dou
et al. 2011; Gonzalez et al. 2011; Bastard et al. 2013). In
Europe, the response to ART and mortality is similar for
both sexes (Perez-Molina et al. 2012; Thorsteinsson et al.
2012).
Variation in disease severity
There may be variation in disease stage at presentation,
with more advanced disease present at time of surgery in
East Africa, compared with other regions (Table 5; Chisi
et al. 2006; Waddell et al. 2010; Kao et al. 2012;
Makupa et al. 2012). This may reflect delayed presenta-
tion to ophthalmic services in this region, leading to more
advanced pathology by the time of surgery. Histopatho-
logical reporting is also subjective, and pathologists may
not always grade tumours the same way (Margo et al.
2002). Alternatively, the disease may be intrinsically
more aggressive in the East African region or HIV
worsens disease progression.
Risk factors
Various factors are thought to influence the causation of
OSSN, but it is not clear how they interact or which is
the most potent. The rising incidence of OSSN in recent
decades may be driven by increased prevalence of these
factors. We found no systematic reviews of risk factors
for OSSN after the literature search. Of the case–control
studies found, two in Uganda and Australia examined the
association with solar exposure; six in Africa examined
the association with HIV; sixteen examined the associa-
tion with HPV; seven in Africa, five in Asia, one in
Brazil, two in USA and one in Australia. Two studies
examined cigarette smoking in Uganda.
Ultraviolet solar radiation. Several cutaneous malignan-
cies, including melanoma and SCC, have a strong associ-
ation with solar radiation. It was first noted in the 1960s
that SCCC was relatively common in East Africa, and
this apparent excess risk was attributed to higher expo-
sure to sunlight (Templeton 1967). There is a strong rela-
tionship between the incidence of SCCC and increasing
Ultraviolet (UV) levels (Newton et al. 1996). Using IARC
data and published measurements of ambient solar ultra-
violet light, the incidence of SCCC was found to reduce
by 49% for every 10° increase in latitude from 1.2 cases/
year/100 000 (Table 7) in Uganda (latitude 0.3°) to
<0.02/year/100 000 in the UK (latitude > 50°). More
recently, the National Institutes of Health/American
Association of Retired Persons (NIH-AARP) Diet and
Health Study in the USA found a slightly lower risk of
SCCC in those who lived >35° compared with ≤35° from
the equator, although this was not statistically significant
(adjusted Hazard Ratio = 0.92, 95% CI: 0.49–1.71; Em-
manuel et al. 2012). The USA has comparatively lower
HIV prevalence, solar irradiance and incidence of OSSN
than Africa, which is bisected by the equator. The high
incidence of ocular SCC near the equator may be related
to high solar irradiance (the amount of solar radiant
energy incident on a surface per unit area and per unit
time) in the world (World Energy Council 2007).
A case–control study in Uganda adjusted for age, sex,
residential district, and HIV serostatus demonstrated that
the risk of OSSN was higher with increasing time spent
Table 4 The age and sex of patients affected by ocular surface squamous neoplasia (OSSN)
Year (ref.) Country Mean age (years) Male (%) Female (%) Male:Female ratio
1995 (Ateenyi-Agaba 1995) Uganda 33 52 48 1:2.3
2008 (Spitzer et al. 2008) Malawi 33 42 58 1:2.1
2010 (Simbiri et al. 2010) Botswana 39 39 61 1:1.6
2003 (Pola et al. 2003) Zimbabwe 35 30 70 1:1.4
2002 (Mahomed & Chetty 2002) S. Africa 37 50 50 1:1.3
2006 (Chisi et al. 2006) Kenya 38 50 50 1:1
2012 (Makupa et al. 2012) Tanzania 39 32 68 1:1
2009 (Ogun et al. 2009) Nigeria 54 43 57 1:0.9
1999 (Tunc et al. 1999) USA 64 70 30 1:0.4
2002 (McKelvie 2002) Australia 69 77 23 1:0.3
© 2013 The Authors. Tropical Medicine and International Health published by John Wiley & Sons Ltd. 1429
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in daylight (Waddell et al. 2010). Compared with those
who reported spending up to 1 h a day in direct sunlight,
the odds ratio (OR) for those who spent 2–4 h was 1.7
(95% CI: 1.2–2.4), and for those who spent 5 or more
hours a day, it was 1.8 (95% CI: 1.1–3.1). A case–con-
trol study in Australia reported that the strongest risk
factor was a past history of skin cancer (OR = 15, 95%
CI: 2.0–113.6), although other factors, including outdoor
activity, pale skin and irides and propensity to burn, were
also important (Lee et al. 1994).
More direct evidence for UV radiation induced damage
in the pathophysiology of SCCC was described in another
case–control study in Uganda in which 52% of the cases
had mutations in the tumour suppressor gene TP53
compared with 14% of controls (Ateenyi-Agaba et al.
2004a). The mutations were mainly of the CC TT type,
consistent with UV-induced mutagenesis. This gene also
downregulates the replication of HPV type 16 via the
viral E2 protein, suggesting that its mutation may allow
replication of HPV particles (Brown et al. 2008). Further,
exposure to UV radiation is associated with altered
expression of matrix metalloproteinases (MMPs) and the
tissue inhibitors of these metalloproteinases (TIMPs),
molecules that may be responsible for tissue invasion and
metastasis of tumours (Ng et al. 2008).
In addition, OSSN lesions occur more often at the
limbus. A study in Uganda demonstrated that tumours
almost always occur in sun-exposed areas of the eye
(Waddell et al. 2006). It is thought that the human eye is
more exposed laterally, making this a large collecting
zone of peripheral sunlight, which, depending on the
incident angle and radius of curvature of the cornea, is
focused on the limbus, lens and lid margin, which are the
main foci of sun-related eye diseases such as pterygium,
OSSN, cataract and lid malignancies (Maloof et al.
1994). Low doses of ambient sunlight received on every
day exposure inhibit immunity in the skin and internal
organs (Halliday et al. 2012).
HIV. There is strong evidence that HIV is a major risk
factor for OSSN. Uganda, which had a cancer registry
since 1951, was the first country to report a dramatic
increase in the annual incidence of SCCC shortly after the
outbreak of HIV/AIDS. There was a sixfold increase from
0.6 cases/year/100 000 between 1970 and 1988 to 3.5/
year/100 000 by 1992 (Figure 4; Ateenyi-Agaba 1995). A
marked rise was also observed in the USA with the onset
of the HIV pandemic (Guech-Ongey et al. 2008). At the
same time, a US study observed a strong association in an
HIV-infected cohort (OR = 13.0, 95% CI: 4–34; Goedert
& Cote 1995). In Tanzania, regional incidence rates were
significantly correlated with regional HIV prevalence
(Pearson’s r = 0.53, P = 0.03; Furahini & Lewallen
2010). The majority of patients (60–77%) with OSSN
seen in Africa are HIV-infected (Table 6). A meta-analysis
of 6 case–control studies (Table 7) in Uganda, Rwanda
and Zimbabwe shows a strong association with HIV infec-
tion (pooled OR = 6.17, 95% CI: 4.83–7.89; Figure 5).
The association with HIV suggests that immunosup-
pression plays a role in OSSN; however, a linear associa-
tion between the CD4 lymphocyte count and OSSN has
not been confirmed. A cross-sectional study conducted in
Tanzania found a median CD4 cell count of 71 cells/ll
among HIV-infected individuals with OSSN (Makupa
et al. 2012). HIV-infected cases tended to have larger
lesions: 71% had lesions >5 mm in diameter vs. 27%
among HIV-negative individuals (OR = 3.13, 95% CI:
1.5–6.5). HIV-infected cases were also more likely to
develop recurrent tumours within a year of excision (82%
vs. 18%; OR = 3.54, 95% CI: 1.12–11.2). However,
there was no significant trend found between CD4 count
and the grade of OSSN (P = 0.94). In a Ugandan study,
Table 5 Stages of ocular surface squamous neoplasia (OSSN) seen at presentation in Africa and USA
Country year (ref.)
Stage of OSSN, n (%)
Mild
dysplasia
(CIN I)
Moderate
dysplasia
(CIN II)
Severe
dysplasia
(CIN III)
Carcinoma
in situ (CIS)
Well
differentiated
SCC
Moderately
differentiated
SCC
Poorly
differentiated
SCC
Kenya 2006 (Chisi et al. 2006) 7 (21.9) 1 (3.1) 9 (28.1) 15 (46.9)
Uganda 2008 (de Koning et al. 2008) 17 (21.0) 18 (22.2) 22 (27.2) 0 (0) 24 (29.6)
Uganda 2010
(Ateenyi-Agaba et al. 2010)
39 (29.3) 94 (70.7)
Uganda 2010 (Waddell et al. 2010) 48 (15.1) 66 (20.8) 81 (25.5) 0 (0) 123 (38.7)
Tanzania 2012 (Makupa et al. 2012) 28 (21.2) 73 (55.3) 0 (0) 31 (23.5)
Malawi 2013 (Tiong et al. 2013) 1 (2.0) 5 (10.2) 9 (18.4) 17 (34.7) 17 (34.7)
USA 2012 (Kao et al. 2012) 48 (8.1) 98 (16.4) 59 (9.9) 322 (54.0) 69 (11.6)
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among 112 HIV-infected cases of CIN and invasive SCC,
the median CD4 count at diagnosis was 111 cells/lL
(IQR; 62–221; Waddell et al. 2006). Excess risks standar-
dised incidence ratio (SIR = 19.5, 95% CI: 6.3–45.5) have
also been observed among a cohort of kidney transplant
recipients in Australia suggesting that immune suppression
from other causes may play a role (Vajdic et al. 2007).
HAART does not reduce the incidence of SCCC
according to data from the US HIV/AIDS Cancer Match
(HACM) Study (Guech-Ongey et al. 2008) which
compared SIRs in the pre-HAART and HAART eras
among 491 048 adults aged ≥15 years with HIV/AIDS
diagnosed from 1980 to 2004. The SIRs here estimate
the excess risk of SCCC attributable to HIV/AIDS com-
pared with a population with negligible HIV/AIDS preva-
lence and were similar at 12.0 (95% CI: 5.5–22.8) and
12.6 (95% CI: 4.6–27.4) in the pre- and post-HAART
eras, respectively (P = 0.79). There is, however, a case
report of ART causing tumour regression in an otherwise
inoperable case (Holkar et al. 2005).
Human papilloma virus. The relationship between
human papilloma virus (HPV) and OSSN is rather
controversial with variable results. (Tulvatana 2003;
Moubayed et al. 2004; Sen et al. 2007; de Koning et al.
2008; Guthoff et al. 2009; Simbiri et al. 2010; Yu et al.
2010). A review of 12 case series and 17 case–control
studies concluded that there was no causal association
between mucosal HPV types and OSSN while the role of
cutaneous types was uncertain (de Koning et al. 2008).
The studies included used different methods for testing of
HPV (including PCR and serology), and different HPV
types were examined. Conversely, a random-effects
meta-analysis of various case–control studies shows that
OSSN is associated with HPV infection in sub-Saharan
Africa (pooled OR = 2.64, 95% CI: 1.27–5.49) and
worldwide (pooled OR = 4.00, 95% CI: 2.11–7.57; Fig-
ure 6). The prevalence of HPV in OSSN ranges from 0%
to 100% depending on geographical region with subtypes
HPV18 and HPV16 being the most common (Table 8; di
Girolamo 2012). Most African studies report prevalence
of 75–85% (Ateenyi-Agaba et al. 2004b; Simbiri et al.
2010; Yu et al. 2010). HPV is more commonly isolated in
OSSN than pterygium – on average, considering studies
from different regions of the world, 33.8% of OSSN
lesions and 18.6% of pterygia are HPV positive (di Girol-
amo 2012). There may be a true geographical variation in
the prevalence of HPV in OSSN.
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Figure 4 Sudden rise in the annual
incidence rates of conjunctival SCCC in
Kampala with the onset of the HIV
pandemic – number of cases shown
(Ateenyi-Agaba 1995).
Table 6 Prevalence of HIV infection in cases of squamous cell carcinoma of the conjunctiva in Africa
Year (ref.) Country Study period HIV prevalence in SCCC cases (%)
2012 (Makupa et al. 2012) Tanzania 2005–2008 60
2011 (Osahon et al. 2011) Nigeria 1999–2009 75
2002 (Mahomed & Chetty 2002) South Africa 1995–1997 71
1995 (Ateenyi-Agaba 1995) Uganda 1990–1991 75
1996 (Waddell et al. 1996) Uganda 1993–1994 71
2003 (Porges & Groisman 2003) Zimbabwe 1993–1995 91
2001 (Newton et al. 2001) Uganda 1994–1998 77
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Differences in HPV prevalence in OSSN may be influ-
enced by patient selection, sample handling in the operat-
ing theatre, preparation, storage, overseas shipping and
the detection method. Variations may also be due to
different testing methodology and the specific HPV types
tested for. Most existing molecular diagnostic tests
applied in OSSN testing for HPV were developed for
cervical tissue testing. The sensitivity and specificity of
various polymerase chain reaction (PCR) tests varies and
may be influenced by various factors including the PCR
design (nested, broad spectrum or type-specific), size of
amplified product and choice of polymerase used (Munoz
et al. 2012; Mesher et al. 2013). Detection of E6/E7
mRNA transcripts by quantitative reverse transcriptase–
PCR (qRT-PCR) has been proposed as the gold standard
for HPV testing (Smeets et al. 2007). However, RNA is
unstable limiting this test to fresh frozen tissue (Kim
et al. 2013). Testing for HPV DNA by PCR from paraf-
fin-embedded archived tumour blocks may be compli-
cated by contamination between samples at the time of
initial tissue sectioning for DNA harvest (Boyd et al.
1996; Iftner & Villa 2003).
Generally, only a limited subset of HPV types has been
investigated among OSSN cases. There are 170 genotypes
of HPV described to date, which are broadly subdivided
into cutaneous and mucosal types (de Villiers 2013).
There are conflicting reports on which of these two are
more commonly associated with OSSN. One study
conducted in Uganda reported that among OSSN cases,
the prevalence of mucosal types was higher than cutane-
ous types (38% vs. 22%) while from another study in
the same population, the prevalence of cutaneous types
was higher than mucosal types (43.6% vs. 6.8%;
Table 8; de Koning et al. 2008; Ateenyi-Agaba et al.
2010). Multiple HPV types have been found in individual
patients with OSSN tumours. One Ugandan study
reported multiple HPV types in 57.1% of SCCC and
75% of dysplasia cases by PCR (Ateenyi-Agaba et al.
2010). In Botswana, multiple HPV types were identified
in all OSSN and all pterygium specimens by DNA
sequencing (Simbiri et al. 2010). The HPV types found
by sequencing ranged from 4 to 21 types per sample. The
same study also described co-infection with multiple
other viral types per individual in 17 of 18 (94%) histo-
logically proven OSSN specimens by PCR; 83% were
positive for Epstein–Barr virus (EBV), 72% were HPV
positive, 67% were Kaposi’s sarcoma-associated herpesvi-
rus (KSHV) positive, 67% were herpes simplex virus
(HSV-1/2) positive and 56% were cytomegalovirus
(CMV) positive. All the pterygium specimens from that
study similarly had multiple viruses; 75% were positive
for each of EBV, KSHV, CMV and HSV while 50% were
Overall  (I-squared = 52.7%, P = 0.060)
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Figure 5 Meta-analysis of case-control studies of HIV infection in ocular surface squamous neoplasia (OSSN) in Africa (fixed effect).
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HPV positive. The proportion of HPV infection in this
series was much higher than any other studies in the
region have reported raising the question whether this
could be due to the methodology used.
The mechanism by which HPV is associated with
OSSN is unknown. HPV is associated with causation of
metaplasia in squamocolumnar epithelial transition zones
such as the corneoscleral limbus and eyelid skin of the
eye, the cervix and anus where there is active cell turn-
over and continuous cell division to replace desquamated
cells (Chow et al. 2010). HPV also promotes degradation
of the p53 gene (Scheffner et al. 1990).
The epidemiology of OSSN is closely related to that of
cervical cancer with respect to high incidence in Africa
and the association with HIV and HPV mainly types 18
and 16 (Sun et al. 1997; Clifford et al. 2003; Stanley
2010). A meta-analysis of HPV prevalence reports world-
wide shows that Africa has the highest adjusted preva-
lence (22.1%; 95% CI: 20.9–23.4%) among women with
cytologically normal cervical pap smears using
PCR-based or high-risk Hybrid Capture 2 (HC-2) tech-
nology to detect HPV DNA (de Sanjose et al. 2007).
Whether vaccination against HPV may help to reduce the
incidence of OSSN remains to be seen (Hughes et al.
2008).
Occupation. Outdoor occupations have been associated
with OSSN, probably related to UV solar radiation
exposure. In Uganda, those with outdoor occupations
had an OR of 1.7 (95% CI: 1.1–2.6) compared to those
with indoor occupations (Waddell et al. 2010). Another
in Uganda reported that 74% of 133 patients with
SCCC or dysplasia had outdoor occupations (Ateenyi-
Agaba et al. 2010). In Japan, exposure to petroleum
products was also described as a risk factor for conjunc-
tival intraepithelial neoplasia (synonym of OSSN) in a
Table 7 Characteristics of case–control studies included in the meta-analysis of HIV as a risk factor of ocular surface squamous
neoplasia (OSSN)
Study period (ref.), Country Cases Controls
1989–1990
(Kestelyn et al. 1990),
Rwanda
11 patients with clinical evidence of conjunctival
dysplasia or malignancy seen at
Centre Hospitalier de Kigali
22 controls. 2 controls per case
from the same area matched for age
and sex within 5 years. Referrals from
elsewhere were excluded
1990–1991
(Ateenyi-Agaba 1995),
Uganda
48 patients with conjunctival growths who presented
to the eye clinic at Mulago Hospital, Kampala
48 patients matched for age and sex
attending the same eye clinic with
other eye diseases
1993–1994
(Waddell et al. 1996),
Uganda
38 patients in seven countrywide eye clinics including
New Mulago Hospital, Kampala who had suspicious
conjunctival lesions had excision biopsy of the lesion
76 controls. 2 controls per case matched
for age and sex. 16 Controls were
patients in the eye clinic without
neoplasia or clinical features of HIV
disease; the remainder were general
(non-eye clinic) anonymous outpatients
at the same health units
1993–1995
(Porges & Groisman 2003),
Zimbabwe
13 cases from patients who underwent excisional biopsy
for conjunctival lesions at Bindura Provincial Hospital
(Mashonaland Central, Zimbabwe)
7 controls. Patients were from the same
group as cases but had benign lesions
on histology
1994–1998
(Newton et al. 2001),
Uganda
22 cases. Patients aged >15 years with a provisional
diagnosis of cancer from all wards and out-patient
clinics of the 4 main hospitals in Kampala: Mulago,
Nsambya, Mengo and Rubaga
112 controls. 93 patients with tumours
not suspected to be of infectious
aetiology and 19 with non-malignant
conditions
2001–2005
(Waddell et al. 2010),
Uganda
318 cases recruited from country-wide ophthalmology
clinics in Uganda. Anyone with a suspected OSSN
was offered surgical treatment and histology,
together with enrolment into a case-control study
762 controls were recruited from 2 sources.
The first group comprised patients
attending the ophthalmology clinics
with concerns or conditions other than
OSSN. This group also included those
individuals who were originally recruited
as cases, but where histology subsequently
revealed another diagnosis. The second
group comprised people who were
recruited through the voluntary HIV
counselling and testing (VCT) service
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small age–sex-matched case–control study (Napora et al.
1990). Exposure to smoke from burning wood in the
kitchen was described as a risk factor for cervical cancer
among HPV-infected women in Honduras (Velema et al.
2002).
Cigarette smoking. Cigarette smoking is implicated in
other squamous cell cancers (Haverkos 2004). There is,
however, evidence of no effect from smoking on OSSN in
Africa. In Uganda, two case–control studies showed that
current smokers were not at a significantly higher risk for
OSSN than non-smokers (Waddell et al. 2010; Ateenyi-
Agaba et al. 2010; pooled OR = 1.40; 95% CI: 0.94–
2.09; Figure 7). In a Nigerian series of 37 SCCC cases,
only two patients (5.4%) had a history of cigarette smok-
ing (Ogun et al. 2009) while in a series from Australia, 5
of 11 cases of SCCC (45%) were smokers (McKelvie
2002).
Allergy. There is little evidence that allergic conjunctivi-
tis is a risk factor. Among 215 SCCC cases in Tanzania,
1.9% had allergic conjunctivitis (Poole 1999). In
Rwanda, allergic conjunctivitis was found in 4% of chil-
dren and was responsible for 3–6% of hospital visits of
all ages (de Smedt et al. 2013). In a case–control study in
Uganda, none of the cases of OSSN had a history of
allergic eye disease (Waddell et al. 2010). However, a
case series of SCCC from Germany reported that 6/10
cases had atopic eczema, so this may be of more
importance in temperate climates (Heinz et al. 2003).
NOTE: Weights are from random effects analysis
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Figure 6 Meta-analysis of case-control studies of human papilloma virus (HPV) infection in ocular surface squamous neoplasia
(OSSN) (random effects).
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Xeroderma pigmentosum. Xeroderma pigmentosum
(XP), a rare, inherited skin disease characterised by high
sensitivity to UV damage is associated with a high preva-
lence (40%) of specific mutations of the TP53 tumour
suppressor gene (Dumaz et al. 1993). Over a 25-year
period in Zimbabwe, in a series of 12 cases, 2 had SCCC
while the rest had SCC of the skin, lip or tongue (Chid-
zonga et al. 2009). From a series of 7 XP cases in India,
6 of the 14 eyes (42.9%) had invasive SCC and eight eyes
(57.1%) had CIN (Gupta et al. 2011). A larger series of
32 cases in France found that 59% of them had ocular
and periocular malignancies (Touzri et al. 2008).
Vitamin A deficiency. The importance of vitamin A in
maintaining the health of the ocular surface is well
known, but the role of vitamin A deficiency in OSSN has
not been established. Deficiency of vitamin A induces
keratinisation of the ocular surface (Beitch 1970; Pfister
& Renner 1978). Keratinisation is commonly observed as
leucoplakia in OSSN lesions (Figure 1). There is a syner-
gistic interaction between vitamin A and zinc in mainte-
nance of the corneal and conjunctival epithelium
(Kanazawa et al. 2002). In South Africa, it was shown
that 54% of HIV-infected adults are deficient in vitamin
A (plasma retinol <1.05 lM) and 33% deficient in zinc
(<10.7 lM; Visser et al. 2003). In Ethiopia, 53% of
HIV-infected adults were deficient in vitamin A (Fufa
et al. 2009). As most patients with OSSN are also
HIV-infected, it is plausible that vitamin A deficiency
contributes to the aetiology.
Other risk factors. There is limited evidence of a role for
exposure to dust, ocular trauma and pre-existing benign
conjunctival lesions such as pterygia and pingueculae
(Templeton 1967; Margo & Groden 1986; Waddell et al.
2010).
Protective factors. One of the Ugandan case–control
studies found that some factors are associated with a
lower risk for SCCC such as higher personal income
(adjusted OR = 0.4, 95% CI: 0.3–0.7) and decreasing
age at leaving home (P = 0.05), perhaps reflecting less
exposure to sunlight consequent to rural-to-urban
migration (Newton et al. 2002).
Aetiological model of OSSN
Various models have been proposed to simultaneously
address the role of two or more risk factors in cancer
causation within hierarchical levels (Victora et al. 1997).
Most such models focus on social and environmental
hypothesis but do not incorporate biological factors. A
recently proposed framework called Multi-level Biological
And Social Integrative Construct (MBASIC) includes
Overall  (I-squared = 69.0%, P = 0.072)
Study
Ateenyi 2010
Waddell 2010
Cases
133
299
Controls
284
754
1.40 (0.94, 2.09)
OR (95% CI)
0.90 (0.48, 1.72)
1.92 (1.15, 3.22)
100.00
Weight
%
50.89
49.11
.5 1 2 3 4
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Figure 7 Meta-analysis of case-control studies in Uganda on cigarette smoking and ocular surface squamous neoplasia (OSSN) in
Africa (fixed effect).
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biological factors together with macro-environmental and
individual level factors (Lynch & Rebbeck 2013). Using
the existing evidence reviewed in this article, we propose
an aetiological model that might explain how the risk
factors discussed may be involved development of OSSN
(Figure 8).
Conclusions
OSSN is a disease of increasing importance in Africa. A
triad of ultraviolet solar radiation, HIV and HPV form
the major risk factors and this may explain the high inci-
dence rates in Africa. There is evidence from case–control
studies that exposure to UV radiation, outdoor occupa-
tions – perhaps due to exposure to sunlight, HIV and
HPV infection are associated with a higher risk for
OSSN. These studies also show no evidence of effect of
cigarette smoking. Dust, ocular trauma and pre-existing
benign conjunctival tumours may play a role. Although
mentioned in the literature, the effect of atopy and xero-
derma pigmentosa is unclear. The effect of vitamin A
deficiency has not been examined in case–control studies.
The highest incidence of OSSN is found in Africa, where
males and females are equally affected, unlike other conti-
nents where male disease predominates. This probably
reflects that African women have increased risk due to their
higher prevalence of HIV and HPV infections. As people
with HIV are living longer, and given no evidence that
ART reduces risk of OSSN, one could expect incidence of
OSSN to increase in Africa in coming years.
Residence near
     equator
Outdoor
occupation
Solar UV
radiation
Altered expression of
MMPs and TIMPs
p 53 genetic mutations
& degradation
Impaired tumor
suppressive effect
Impaired
downregulation of
HPV E2 proteins
HPV infection or
reactivation of
latent infection
Metaplasia at squamo-columnar
transition epithelia eg. limbus
?
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No evidence of effect
Tissue invasion and spread
of malignant cells (OSSN)
MMPs - matrix metalloproteinases
TIMPs - tissue inhibitors of metalloproteinases
HPV E6 protein
promotes degradation
of p53 gene
Immune
suppression
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infected cells
   HIV
infection
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UV radiation damage
Figure 8 An aetiological model
illustrating how ocular surface squamous
neoplasia (OSSN) might develop. MMPs,
matrix metalloproteinases; TIMPs, tissue
inhibitors of metalloproteinases.
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Currently, the best available options for OSSN control
remain early detection and effective treatment. However,
there are no early non-invasive diagnostic methods in use
and no trial evidence to guide treatment. OSSN is
currently largely neglected by both eye and HIV care
programmes. Eye care programmes prioritise preventable
blindness while OSSN often in early stages does not
affect vision. OSSN may, however, lead to facial disfig-
urement and death in late stages. In Africa, a key
research question is whether scale-up of ART and HPV
vaccination will impact on OSSN.
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